You can narrow down the results using the filters
-
Reducing prehospital delay in Acute Myocardial Infarction
-
Hip Fracture Intervention Trial
Many patients with hip fracture end up disabled or in nursing homes in the year following fracture. Current treatment protocols do not systematically address risk factors for disability. We will recruit 600 patients who have fractured their hip. Subjects will be randomized to receive usual care or the HIPFIT intervention, which includes targeted treatments for depression, muscle weakness, poor gait and balance, malnutrition, vitamin D deficiency, poor vision, environmental hazards in the home, social isolation, and low self-efficacy, as needed. The two groups will be followed for 12 months to determine differences in disability and need for residential care.
-
A randomised, prospective double-blind trial of long-term daily versus weekly azithromycin in cystic fibrosis
-
A randomized controlled trial of the effect of substantial weight loss on obstructive sleep apnoea as measured by the apnoea/hypopnoea index.
-
A prospective randomized controlled intervention study of conventional management versus the placement of the Lap-Band System in severely obese adolescents in effecting weight loss.
-
The effect of weight loss on Type 2 Diabetes: a prospective randomized controlled trial of best practice medical management versus the placement of the Lap-Band System on HbA1c concentration.
-
THE EFFECT OF AN ALGORITHM BASED SEDATION GUIDELINE ON THE DURATION OF MECHANICAL VENTILATION FOR INTENSIVE CARE PATIENTS IN AN AUSTRALIAN INTENSIVE CARE UNIT
-
Mite and endotoxin exposure in the beds of children with asthma (NHMRC 352427)
-
Fungal allergy and domestic exposure to fungi in cystic fibrosis (Australian Cystic Fibrosis Research Trust 2004/052)
-
Personal exposure to fungal allergens in asthma (NHMRC 253818)